Close

Watson introduces generic version of Fortamet

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

Chugai Pharmaceutical and GSK Sign Exclusive License Agreement for Anti-Dengue Antibody AID351

Japan-based Chugai Pharmaceutical has entered into an exclusive license...

Advanced Molecular Research Tools Expanding Translational Applications

Clinical research organizations are currently integrating advanced molecular research...

Nucleic Acid Testing Workflows Strengthening Molecular Research

Pharmaceutical laboratories are currently standardizing nucleic acid testing workflows,...
- Advertisement -

Watson Pharmaceuticals has introduced an authorized generic version of Fortamet as a part of an agreement with Shionogi.

The company began the shipment of generic Fortamet (metformin hydrochloride extended-release tablets). Fortamet is indicated as an adjunct to diet and exercise to lower blood glucose for patients 17 years of age or older. Fortamet had combined brand and generic sales of approximately $82m for the twelve months ending 28 February 2012, according to IMS Health data.

World Pharma Today brings together the global pharmaceutical industry — from R&D leaders and regulatory affairs professionals to manufacturers and distribution executives — through trusted editorial, market intelligence, and digital engagement.

Our 2026 Media Pack offers integrated solutions to reach your audience:

  • Magazine & Digital Editions Showcase your brand within premium pharmaceutical industry coverage read by executives and decision - makers worldwide.
  • Industry Insights & Reports Align with data - driven analysis, trend reports, and regional roundups across the global pharmaceutical and life sciences value chain.
  • Brand Authority & Credibility Position your company as a thought leader through expert commentary, interviews, and special features.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Latest stories

Related stories

Chugai Pharmaceutical and GSK Sign Exclusive License Agreement for Anti-Dengue Antibody AID351

Japan-based Chugai Pharmaceutical has entered into an exclusive license...

Advanced Molecular Research Tools Expanding Translational Applications

Clinical research organizations are currently integrating advanced molecular research...

Nucleic Acid Testing Workflows Strengthening Molecular Research

Pharmaceutical laboratories are currently standardizing nucleic acid testing workflows,...

Capsule-in-Capsule Systems Expanding Oral Dosage Design

The pharmaceutical sector has witnessed a growing demand for...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »